Drug Profile
HSRx 888
Alternative Names: Donepezil-combination-HSRxLatest Information Update: 22 Feb 2022
Price :
$50
*
At a glance
- Originator HerbalScience Group
- Developer HSRx Biopharmaceutical
- Class Antidementias; Nootropics; Small molecules
- Mechanism of Action Acetylcholinesterase inhibitors; Amyloid beta-protein inhibitors; Tau protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Alzheimer's disease